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ABSTRACT 
The early detection of cancer is crucial for successful treatment. Medical researchers have investigated a 
number  of  early-diagnosis  techniques.  Recently,  they  have  discovered  that  some  cancers  affect  the 
concentration of certain molecules in the blood, which allows early diagnosis by analyzing the blood mass 
spectrum.  Researchers  have  developed  several  techniques  for  the  analysis  of  the  mass-spectrum  curve 
analysis and used them for the detection of prostate, ovarian, breast, bladder, pancreatic, kidney, liver and 
colon cancers. In this study we propose a new technique that uses the spectral domain features such as 
wavelet transform and Fourier transform for the analysis of the ovarian cancer data to differentiate between 
normal and patients with malignant cancer. We used two different classifiers for the original data, the first 
one is a feed forward artificial neural network classifier which gave a sensitivity of 96%, specificity of 88% 
and  accuracy  of  94%.  The  second  used  classifier  is  the  linear  discriminant  analysis  classifier  which 
separated the cancer from healthy samples with sensitivity of 79%, specificity of 75% and accuracy of about 
81%. After transforming the data to the spectral domain using the Fourier transform the performance was 
degraded. The experimental results showed that the performance of the wavelet transform based system was 
superior to other techniques as it gave a sensitivity of 98%, specificity of 96% and accuracy of 95%. 
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1. INTRODUCTION 
  Pathological  changes  within  an  organ  might  be 
reflected  in  proteomic  patterns  in  serum.  We 
developed a bioinformatics tool and used it to identify 
proteomic patterns in serum that distinguish neoplastic 
from non-neoplastic disease within the ovary. Profile 
patterns are generated using Surface-Enhanced Laser 
Desorption  and  Ionization  (SELDI)  protein  mass 
spectrometry  (Fig.  1).  This  technology  has  the 
potential  to  improve  clinical  diagnostics  tests  for 
cancer pathologies. The goal is to select a reduced set 
of  measurements  or  “features”  that  can  be  used  to 
distinguish between cancer and control patients. These 
features  will  be  ion  intensity  levels  at  specific 
mass/charge values. 
  The blood mass spectrum is a curve (Fig. 2), where 
the  x-axis  shows  the  ratio  of  the  weight  of  a  specific 
molecule to its electric charge and the y-axis is the signal 
intensity  for  the  same  molecule.  The  mass-spectrum 
analysis is a fast inexpensive procedure based on a sample 
of a patient’s blood and it may potentially allow cancer 
screening with little discomfort to a patient (Bakhtiar and 
Nelson, 2001; Bakhtiar and Tse, 2000; Yates, 2000). 
  In this study we propose a new technique that uses 
the spectral domain features such as wavelet transform 
and  Fourier  transform  for  the  analysis  of  the  ovarian 
cancer data to differentiate between normal and patients 
with  malignant  cancer.  When  feed  forward  artificial 
neural  network  classifier  is  compared  with  LDA 
classifier, it gives more efficiency than LDA but it gives 
less efficiency when wrapping curve is performed. Ahmed Farag Seddik et al. / Journal of Computer Science 9 (8): 1061-1068, 2013 
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Fig. 1. Surface-enhanced laser desorption and ionization (SELDI) protein mass spectrometry 
 
 
 
Fig. 2. The blood mass spectrum Ahmed Farag Seddik et al. / Journal of Computer Science 9 (8): 1061-1068, 2013 
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Fig. 3. Simple block diagram for the first technique 
 
 
 
Fig. 4. Simple block diagram for the second technique Ahmed Farag Seddik et al. / Journal of Computer Science 9 (8): 1061-1068, 2013 
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1.1. Literature Review 
  Medical researchers have developed techniques for 
the detection of early cancer based on protein markers, 
which are certain molecules in body tissues and fluids 
(Poon and Johnson, 2001), but these techniques are often 
inaccurate.  For  example,  the  specificity  of  an  antigen 
method for the prostate-cancer detection is only 25-30%, 
although its sensitivity is high (Adam et al., 2001); as 
another example, the sensitivity of a similar method for 
breast cancer is 23% and its specificity is 69% (Li et al., 
2002).  Recently,  researchers  have  developed  a  new 
cancer-detection method based on the application of data 
mining  to  the  mass  spectra  of  patients’  tissue  cells, 
blood, serum and other body fluids (Petricoin and Liotta, 
2002; Petricoin et al., 2002c; Wulfkuhle et al., 2003). 
  In  previous  reports,  researchers  have  compared 
results  obtained  with  several  well-known  classification 
methods  to  distinguish  ovarian  cancer  patients  from 
normal individuals based on MS data obtained on serum 
samples.  Overall,  they  have  found  that  the  Random 
Forest (RF) (Wu et al., 2003) approach both leads to an 
overall lower misclassification rate as well as to a more 
stable assessment of classification errors. Therefore, their 
preliminary  analyses  suggest  that  RF  and  methods 
similar in nature to RF may be more useful than other 
methods  to  classify  samples  based  on  MS  data. 
Compared to Linear Discriminant Analysis (LDA) and 
Quadratic  Discriminant  Analysis  (QDA)  methods 
(Huang  et  al.,  2012),  RF  has  the  advantage  of  not 
requiring the number of variables used to be less than the 
number  of  subjects  in  the  study,  which  is  a  clear 
advantage for the analysis of MS data as the number of 
m/z versus intensity data points is very large. In addition, 
RF is able to handle interactions among variables. 
  In this study we proposed the use of feed forward 
artificial neural network as a classifier and compared it 
with the LDA classifier. The proposed technique gives 
higher classification performance than LDA. 
1.2. The Proposed Technique 
  In this study, we used two techniques to reduce 
and  classify  the  extracted  serum  sample  spectrum 
data.  In  the  first  technique,  we  applied  Fourier 
transform or wavelet transform (Fig. 3) on the data. 
Then we used the student t-test to select the features 
and perform classification using feed forward neural 
network.  But  in  the  second  technique,  we  used  the 
principle component analysis to select the features and 
perform  classification  using  linear  discriminant 
analysis (Fig. 4).  
2. MATERIALS AND METHODS 
  The  ovarian  cancer  dataset  in  this  study  comes 
from  the  FDA-NCI  Clinical  Proteomics  Program 
Databank. This study uses the high-resolution ovarian 
cancer  data  set  that  was  generated  using  the  WCX2 
protein array. The sample set includes 95 controls and 
121 ovarian cancers. An extensive description of this 
data  set  and  excellent  introduction  to  this  promising 
technology  can  be  found  in  (Conrads  et  al.,  2004a; 
Petricoin  et  al.,  2002a).  The  dataset  includes  three 
matrices as shown in Table 1. 
  Each column in Y represents measurements taken 
from  a  patient.  There  are  216  columns  in  Y 
representing  216  patients,  out  of  which  121  are 
ovarian  cancer  patients  and  95  are  normal  patients. 
Each row in Y represents the ion intensity level at a 
specific mass-charge value indicated in MZ. There are 
15000 mass-charge values in MZ and each row in Y 
represents  the  ion-intensity  levels  of  the  patients  at 
that  particular  mass-charge  value.  The  variable  grp 
holds  the  index  information  as  to  which  of  these 
samples  represent  cancer  patients  and  which  ones 
represent normal patients. An extensive description of 
this  data  set  and  excellent  introduction  to  this 
promising technology can be found in (Conrads et al., 
2004b; Petricoin et al., 2002b). 
2.1. Feature selection and Ranking 
  This is a typical classification problem in which the 
number of features is much larger than the number of 
observations, but in which no single feature achieves a 
correct  classification,  therefore  we  need  to  find  a 
classifier  which  appropriately  learns  how  to  weight 
multiple  features  and  at  the  same  time  produce  a 
generalized mapping which is not over-fitted.  
2.2. Student T-Test Method 
  A simple approach for finding significant features is 
to  assume  that  each  M/Z  value  is  independent  and 
compute a two-way t-test (Sawilowsky, 2005). We used 
the student t-test method to rank the features and we got 
an index to the most significant M/Z values ranked by the 
absolute  value  of  the  t-test  statistic  value.  This  feature 
selection  method  is  also  known  as  a  filtering  method, 
where the learning algorithm is not involved on how the 
features are selected. In this study we selected the top 200 
features based on the t-test value.  Ahmed Farag Seddik et al. / Journal of Computer Science 9 (8): 1061-1068, 2013 
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2.3. Principal Component Analysis (PCA) 
  It  is  a  way  of  identifying  patterns  in  data  and 
expressing the data in such a way as to highlight their 
similarities and differences (Abdi and Williams, 2010). 
Since patterns in data can be hard to find in data of high 
dimension, where the luxury of graphical representation 
is not available, PCA is a powerful tool for analyzing 
data. In this study we used PCA as a feature reduction 
technique to reduce the  high dimensionality of  feature 
space to only 200 features.  
2.4. Classification 
  After selection of the most 200 significant features 
using one of the feature selection techniques described 
above,  we used this information to classify the cancer 
and normal samples. 
2.5. Using a Feed Forward Neural Network 
  A  neural  network  is  a  massively  parallel 
distributed  processor  made  up  of  simple  processing 
units  that  have  a  natural  tendency  for  storing 
experiential knowledge and making it available for us. 
Artificial Neural Network (ANN) is a type of artificial 
intelligence technique that mimics the behavior of the 
human brain (Hu and Hwang, 2010).  
  First, the data is separated into inputs and targets. 
The significant features identified will act as the inputs 
to the neural network. The targets for the neural network 
will  be  the  logical  indices  of  cancer  samples.  Cancer 
samples  will  hence  be  identified  with  1’s  and  normal 
samples will be identified with 0’s.  
  A  1-hidden  layer  feed  forward  neural  network 
with  5  hidden  layer  neurons  is  created  and  trained. 
The 216 input and target patterns are divided into 60% 
training,  20%  validation  and  20%  for  testing.  The 
training  set  is  used  to  teach  the  network.  Training 
continues as long as the network continues improving 
on  the  validation  set.  The  test  set  provides  a 
completely independent measure of network accuracy. 
  The trained neural network were tested with the testing 
samples we partitioned from the main dataset. The testing 
data was not used in training in any way and hence provides 
an “out-of-sample” dataset to test the network.  
 
Table 1. Dataset 
Data matrix name   Size  
MZ   15000×1 
Y   15000×216 
grp   216×1 
This gave us a sense of how well the network will do 
when tested with data from the real world.  
2.6. Using Linear Discriminant Analysis (LDA) 
  Linear discriminant analysis (Hastie et al., 2005) has 
been explored for the probabilistic classification of healthy 
versus ovarian cancer serum samples using proteomics data 
from  Mass  Spectrometry  (MS).The  linear  discriminant 
analysis  method  consists  of  searching,  some  linear 
combinations of selected variables, which provide the best 
separation between the considered classes.  
3. RESULTS AND DISCUSSION 
  Clinicians  use  three  standard  measures  of  the 
effectiveness  of  diagnosis  techniques:  sensitivity, 
specificity  and  accuracy.  The  sensitivity  is  the 
probability  of  the  correct  diagnosis  for  a  patient  with 
cancer,  the  specificity  is  the  chances  of  the  correct 
diagnosis for a healthy person and the accuracy is the 
chances  of  the  correct  diagnosis  for  the  overall 
population of healthy and sick people.  
  Table 2 depicts that after transforming the data to 
the  spectral  domain  using  the  Fourier  transform  the 
performance was degraded. From Table 2, it is clearly 
noticed that the performance of the wavelet transform 
based  system  was  superior  to  other  techniques  as  it 
gave  a  sensitivity  of  98%,  specificity  of  96%  and 
accuracy of 95%.  
  Also,  we  can  notice  that  feed  forward  neural 
network classifier gives better specificity, sensitivity and 
accuracy than LDA.  
  The  spectral  transformation  for  the  data  using 
Fourier  transform  degraded  the  accuracy  and 
sensitivity  while  maintaining  the  specificity.  On  the 
other  hand,  the  wavelet  transform  increased  the 
performance  of  the  feed  forward  artificial  neural 
network  classifier.  Although  the  performance  of  the 
feed forward neural network is better than LDA the 
wrapping curve of LDA (Fig. 8) is more accurate than 
the feed forward neural network that is because training 
multiple  times  will  generate  different  results  due  to 
different initial conditions and sampling (Fig. 5-7). 
 
Table 2. Comparison between the different methods 
  Specificity   Sensitivity   Accuracy 
 Technique  (%)  (%)  (%) 
Neural network   88   96   94.0  
Neural network with 
fourier transform  88   89   85.0  
Neural network with 
Wavelet transform   98   96   95 .0 
LDA   75   79   80.7  Ahmed Farag Seddik et al. / Journal of Computer Science 9 (8): 1061-1068, 2013 
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Fig. 5. Wrapping curve in feed forward neural network classifier 
 
 
 
Fig. 6. Wrapping curve in feed forward neural network classifier with wavelet transform of data Ahmed Farag Seddik et al. / Journal of Computer Science 9 (8): 1061-1068, 2013 
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Fig. 7. Wrapping curve in feed forward neural network classifier with fourier transform of data 
 
 
 
Fig. 8. Wrapping curve in linear discriminant analysis classifier Ahmed Farag Seddik et al. / Journal of Computer Science 9 (8): 1061-1068, 2013 
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4. CONCLUSION 
  In this study we proposed a new methodology to 
distinguish  between  the  normal  patient  and  cancer 
based  on  the  spectral  domain  features  of  the  data. 
Experimental results have demonstrated that the feed 
forward  neural  network  classifier  gives  better 
specificity,  sensitivity  and  accuracy  than  LDA  and 
after  transforming  the  data  to  the  spectral  domain 
using  the  Fourier  transform  the  accuracy  and 
sensitivity  were  degraded  while  maintaining  the 
specificity. On the other hand, the wavelet transform 
increased  the  performance  of  the  feed  forward 
artificial neural network classifier.  
  The  amount  and  quality  of  the  data  are  key 
components  of  the  diagnostic  accuracy.  The 
measuring  process  may  contain  many  features  that 
create problems for the data mining techniques. The 
datasets  could  be  consisted  of  a  large  volume  of 
heterogeneous  data  fields  which  usually  complicates 
the use of data mining techniques.  
5. REFERENCES 
Abdi, H. and L.J. Williams, 2010. Principal component 
analysis.  WIREs  Comp.  Stat.,  2:  433-459.  DOI: 
10.1002/wics.101 
Adam, B.L., A. Vlahou, O.J. Semmes and G.L. Wright, 
2001. Proteomic approaches to biomarker discovery 
in  prostate  and  bladder  cancers.  Proteomics,  1: 
1264-1270. PMID: 11721637 
Bakhtiar,  R.  and  F.L.S.  Tse,  2000.  Biological  mass 
spectrometry: A primer. Mutagenesis, 15: 415-430. 
PMID: 10970448  
Bakhtiar, R. and R.W. Nelson, 2001. Mass spectrometry 
of the proteome. Mol. Pharmacol., 60: 405-415.  
Conrads, T.P., V.A. Fusaro, S. Ross, D. Johann and V. 
Rajapakse  et  al.,  2004a.  High-resolution  serum 
proteomic  features  for  ovarian  cancer  detection. 
Endoc.  Relat.  Cancer,  11:  163-178.  PMID: 
15163296 
Conrads, T.P., V.A. Fusaro, S. Ross, D. Johann and V. 
Rajapakse,  et  al.,  2004b.  High-resolution  serum 
proteomic  features  for  ovarian  cancer  detection. 
Endocr.  Relat.  Cancer,  11:  163-178.  PMID: 
15163296 
Hastie,  T.,  R.  Tibshirani  and  J.  Friedman,  2005.  The 
Elements  of  Statistical  Learning:  Data  Mining, 
Inference and Prediction. 2nd Edn., Springer, New 
York, ISBN-10: 0387848584, pp: 745.  
Hu,  Y.H.  and  J.N.  Hwang,  2010.  Handbook  of  Neural 
Network  Signal  Processin.  1st  Edn.,  Taylor  and 
Francis, Boca Raton, ISBN-10: 0849323592, pp: 408. 
Huang, H., Y. Liu, L. Bosch, B. Cranen and L. Boves, 
2012.  Knowledge-based  quadratic  discriminant 
analysis.  Proceedings  of  the  IEEE  International 
Conference  on  Acoustics,  Speech  and  Signal 
Processing, Mar. 25-30, IEEE Xplore Press, Kyoto, 
pp:  4145-4148.  DOI: 
10.1109/ICASSP.2012.6288831   
Li, J., Z. Zhang, J. Rosenzweig, Y.Y. Wang and D.W. 
Chan,  2002.  Proteomics  and  bioinformatics 
approaches for identification of serum biomarkers to 
detect  breast  cancer.  Clin.  Chem.,  48:1296-1304. 
PMID: 12142387 
Petricoin, E.F. and L.A. Liotta, 2002. Proteomic analysis 
at  the  bedside:  Early  detection  of  cancer.  Trends 
Biotechnol.,  20:  S30-S34.  DOI:  10.1016/S1471-
1931(02)00204-5 
Petricoin,  E.F.,  A.M.  Ardekani,  B.A.  Hitt,  P.J.  Levine 
and  V.A.  Fusaro  et  al.,  2002a.  Use  of  proteomic 
patterns in serum to identify ovarian cancer. Lancet, 
359: 572-577. PMID: 11867112 
Petricoin,  E.F.,  A.M.  Ardekani,  B.A.  Hitt,  P.J.  Levine 
and  V.A.  Fusaro  et  al.,  2002b.  Use  of  proteomic 
patterns in serum to identify ovarian cancer. Lancet, 
359: 572-577. PMID: 11867112  
Petricoin, E.F., K.C. Zoon, E.C. Kohn, J.C. Barrett and 
L.A. Liotta, 2002c. Clinical proteomics: Translating 
benchside promise into bedside reality. Nature Rev. 
Drug Disco., 1: 683-695. PMID: 12209149  
Poon, T.C.W. and P.J. Johnson, 2001. Proteome analysis 
and its impact on the discovery of serological tumor 
markers.  Clin.  Chim.  Acta,  313:  231-239.  DOI: 
10.1016/S0009-8981(01)00677-5 
Sawilowsky,  S.S.,  2005.  Misconceptions  leading  to 
choosing  the  t-test  over  the  Wilcoxon  Mann-
Whitney  U  test  for  shift  in  location  parameter.  J. 
Mod. Applied Stat. Meth., 4: 598-600.  
Wu, B., T. Abbott, D. Fishman, W. McMurray and G. 
Mor,  2003.  Comparison  of  statistical  methods  for 
classification  of  ovarian  cancer  using  mass 
spectrometry  data.  Bioinformatics,  19:  1636-1643. 
DOI: 10.1093/bioinformatics/btg210  
Wulfkuhle,  J.D.,  L.A.  Liotta  and  E.F.  Petricoin,  2003. 
Proteomic  applications  for  the  early  detection  of 
cancer.  Nat.  Rev.  Cancer,  3:  267-275.  PMID: 
12671665 
Yates, J.R., 2000. Mass spectrometry. From genomics to 
proteomics.  Trends  Genet.,  16:  5-8.  PMID: 
10637622 